Enanta Pharmaceuticals (ENTA) Cash from Investing Activities (2012 - 2026)
Enanta Pharmaceuticals' Cash from Investing Activities was $14.01 million in fiscal Q3 2026 (quarter ended Jun 30, 2026), compared with -$26.48 million a year earlier and up 17.3% from the prior quarter.
Enanta Pharmaceuticals (ENTA) Cash from Investing Activities (2012 - 2026) Analysis & Trends
On a trailing twelve-month basis, Enanta Pharmaceuticals' Cash from Investing Activities was -$19.06 million through Jun 30, 2026; for FY2025 (ended Sep 30, 2025), it was $40.35 million, down 30.7% from FY2024.
- Cash from Investing Activities shows a five-year compound annual growth rate of 15.3% (FY2020 to FY2025).
- In earlier fiscal years, Cash from Investing Activities was $58.24 million in FY2024, -$53.58 million in FY2023, $54.9 million in FY2022 (+48.4%) and $36.99 million in FY2021 (+86.5%).
- The fiscal Q3 2026 figure marks the highest quarterly Cash from Investing Activities since fiscal Q1 2025.
- Per Business Quant data, ENTA's Cash from Investing Activities in the three fiscal quarters before Q3 2026 was $11.94 million (Q2 2026), -$47.3 million (Q1 2026) and $2.3 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | -15.40 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | -1.11 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | -1.20 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -5.60 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -3.11 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -2.91 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | -569.00 Mn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -10.35 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 2.11 Bn |
| 10 | Enanta Pharmaceuticals | 377.40 Mn | -350.60 Mn | - | 14.01 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 14.01 Mn |
| Mar 31, 2026 | 11.94 Mn |
| Dec 31, 2025 | -47.30 Mn |
| Sep 30, 2025 | 2.30 Mn |
| Jun 30, 2025 | -26.48 Mn |
| Mar 31, 2025 | -4.37 Mn |
| Dec 31, 2024 | 68.90 Mn |
| Sep 30, 2024 | 19.07 Mn |
| Jun 30, 2024 | -6.35 Mn |
| Mar 31, 2024 | 58.62 Mn |
| Dec 31, 2023 | -13.12 Mn |
| Sep 30, 2023 | 11.84 Mn |
| Jun 30, 2023 | -145.75 Mn |
| Mar 31, 2023 | 46.77 Mn |
| Dec 31, 2022 | 33.57 Mn |
| Sep 30, 2022 | 28.23 Mn |
| Jun 30, 2022 | 16.22 Mn |
| Mar 31, 2022 | -35.06 Mn |
| Dec 31, 2021 | 45.50 Mn |
| Sep 30, 2021 | 72.68 Mn |
Enanta Pharmaceuticals Cash from Investing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=ENTA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-investing-activities", "ticker": "ENTA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=ENTA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();